Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 979

Harnessing The Power Of Science & Innovation For All — Dr. Anna Laura Ross, Ph.D., Unit Head for Emerging Technologies, Research Prioritization and Support, Science Division, WHO.

Dr. Anna Laura Ross, Ph.D. is the Unit Head for Emerging Technologies, Research Prioritization and Support, in the World Health Organization (WHO) Science Division (https://www.who.int/our-work/science-division), located in Geneva, as well as the Head of the WHO Science Council Secretariat.

Previously at WHO, Dr Ross served as Strategy Technical Manager at Unitaid, their global health initiative that works with partners to bring about innovations to prevent, diagnose and treat major diseases in low-and middle-income countries, with an emphasis on tuberculosis, malaria, and HIV/AIDS and its deadly co-infections, providing strategic and technical support for Unitaid’s strategy, and working to identify the priorities areas for intervention to accelerate innovation for global health.

Continue reading “Dr Anna Laura Ross PhD — Science Division, WHO — Harnessing Power Of Science & Innovation For All” | >

A collaborative research team co-led by City University of Hong Kong (CityU) has developed a wearable tactile rendering system, which can mimic the sensation of touch with high spatial resolution and a rapid response rate.

The team demonstrated its application potential in a braille display, adding the sense of touch in the metaverse for functions such as virtual reality shopping and gaming, and potentially facilitating the work of astronauts, deep-sea divers and others who need to wear thick gloves.

“We can hear and see our families over a long distance via phones and cameras, but we still cannot feel or hug them. We are physically isolated by space and time, especially during this long-lasting pandemic,” said Dr. Yang Zhengbao, Associate Professor in the Department of Mechanical Engineering of CityU, who co-led the study.

Read more | >

(http://www.pharma.unizg.hr/en/about-us/staff/gordan–lauc, 450.html) is Professor of Biochemistry and Molecular Biology at the University of Zagreb, Faculty of Pharmacy and Biochemistry, and Founder and CEO of Genos Ltd. (https://genos-glyco.com/), a research-intensive SME located in Zagreb, Croatia with core of expertise in molecular genetics and glycomics (The comprehensive study the entire complement of sugars, whether free or present in more complex molecules of an organism) and they perform contract research, contract analysis and service for numerous universities, hospitals and private individuals in Europe and overseas.

Prof. Dr. Lauc also is CSO of GlycanAge LTD (https://glycanage.com/), a company that has developed a ground-breaking test that analyses your personal glycobiome for insights in improving your health and monitoring your biological age, and Co-Director of the Human Glycome Project (https://human-glycome.org/).

Prof. Dr. Lauc graduated with a degree in molecular biology at the University of Zagreb Faculty of Science in 1992, and obtained Ph.D. in Biochemistry and the University of Zagreb in 1995. He got his postdoctoral training at the Institute for Medical Physics and Biophysics in Münster and Johns Hopkins University in Baltimore. Since 1993 he has been employed at the Faculty of Pharmacy and Biochemistry in Zagreb. Between 1998 and 2010 he was also part-time employed at the University of Osijek School of Medicine where he founded a DNA laboratory for the identification of war victims and also served as Vice-Dean for Science between 2001 and 2005.

Prof. Dr. Lauc is author of over 100 research papers published in international journals and six international patents. He was invited to lecture at numerous international conferences, elected for visiting professor at the Johns Hopkins University and in 2011 also inducted in the prestigious Johns Hopkins Society of Scholars. If 2012 he was appointed Honorary Professor at the University of Edinburgh and Adjunct Professor at the Edith Cowan University in Perth.

Continue reading “Prof. Dr. Gordan Lauc, Ph.D. — Founder & CEO, Genos; CSO, GlycanAge; Advancing The Glycosciences” | >

A Brazilian study published in Scientific Reports shows that artificial intelligence (AI) can be used to create efficient models for genomic selection of sugarcane and forage grass varieties and predict their performance in the field on the basis of their DNA.

In terms of accuracy compared with traditional breeding techniques, the proposed methodology improved predictive power by more than 50%. This is the first time a highly efficient genomic selection method based on has been proposed for polyploid plants (in which cells have more than two complete sets of chromosomes), including the grasses studied.

Machine learning is a branch of AI and computer science involving statistics and optimization, with countless applications. Its main goal is to create algorithms that automatically extract patterns from datasets. It can be used to predict the performance of a plant, including whether it will be resistant to or tolerant of biotic stresses such as pests and diseases caused by insects, nematodes, fungi or bacteria, and or abiotic stresses such as cold, drought, salinity or insufficient soil nutrients.

Read more | >

Alzheimer’s disease is a brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. In most people with the disease — those with the late-onset type symptoms first appear in their mid-60s. In a study from Brigham and Women’s Hospital, scientists found a new contributor to Alzheimer’s disease.

Read more | >

With Executive Order 14028, a large regulatory push toward mandating the production of a software bill of materials (SBOM) began. As this new buzzword spreads, you’d think it was a miracle cure for securing the software supply chain. Conceptually, it makes sense — knowing what is in a product is a reasonable expectation. However, it is important to understand what exactly an SBOM is and whether or not it can objectively be useful as a security tool.

SBOMs are meant to be something like a nutrition label on the back of a grocery store item listing all of the ingredients that went into making the product. While there currently is no official SBOM standard, a few guideline formats have emerged as top candidates. By far, the most popular is the Software Data Package Exchange (SPDX), sponsored by the Linux Foundation.

SPDX, as with most other formats, attempts to provide a common way to represent basic information about the ingredients that go into the production of software: names, versions, hashes, ecosystems, ancillary data like known flaws and license information, and relevant external assets. However, software is not as simple as a box of cereal, and there is no equivalent to the Food and Drug Administration enforcing compliance to any recommended guidelines.

Read more | >

The tremendous rise in the economic burden of type 2 diabetes (T2D) has prompted a search for alternative and less expensive medicines. Dandelion offers a compelling profile of bioactive components with potential anti-diabetic properties. The Taraxacum genus from the Asteraceae family is found in the temperate zone of the Northern hemisphere. It is available in several areas around the world. In many countries, it is used as food and in some countries as therapeutics for the control and treatment of T2D. The anti-diabetic properties of dandelion are attributed to bioactive chemical components; these include chicoric acid, taraxasterol (TS), chlorogenic acid, and sesquiterpene lactones. Studies have outlined the useful pharmacological profile of dandelion for the treatment of an array of diseases, although little attention has been paid to the effects of its bioactive components on T2D to date. This review recapitulates previous work on dandelion and its potential for the treatment and prevention of T2D, highlighting its anti-diabetic properties, the structures of its chemical components, and their potential mechanisms of action in T2D. Although initial research appears promising, data on the cellular impact of dandelion are limited, necessitating further work on clonal β-cell lines (INS-1E), α-cell lines, and human skeletal cell lines for better identification of the active components that could be of use in the control and treatment of T2D. In fact, extensive in-vitro, in-vivo, and clinical research is required to investigate further the pharmacological, physiological, and biochemical mechanisms underlying the effects of dandelion-derived compounds on T2D.

Keywords: type 2 diabetes, dandelion, chlorogenic acid, chicory acid, taraxasterol, sesquiterpene.

Abbreviations: ADP — adenosine diphosphate; AFLD — alcoholic fatty liver disease; AMPK — adenosine monophosphate-activated protein kinase; ATP — adenosine triphosphate; cAMP — cyclic adenosine monophosphate; CGA — chlorogenic acid; CoA — coenzyme A; CRA — chicory acid; DAG — diacylglycerol; DBD — DNA-binding domain; DNA — deoxyribonucleic acid; DPPH — 2,2-diphenyl-1-picrylhydrazyl; Dw — dry weight; FOS — fructose oligosaccharide; G6P — glucose-6-phosphate; GDP — guanosine 5’-diphosphate; GLP-1 — glucagon-like peptide 1; GLUT2 — glucose transporter 2; GLUT4 — muscle glucose transporter protein 4; GPCR — G protein-coupled receptor; GTP — guanosine triphosphate; HNB — 2-hydroxy-5-nitrobenzenaledehyde; HPLC — high-pressure liquid chromatography; IC50 — half maximal inhibitory concentration; IDF — International Diabetes Federation; IDX-1 — islet duodenum homeobox 1; IL-1α — interleukin 1 alpha; INS-1E — rat insulinoma clonal beta-cell line; IR — insulin receptor; IRS-1 — insulin receptor substrate 1; Km — Michaelis constant; IP3 — inositol triphosphate; IRS-1 — insulin receptor substrate 1; LBD — ligand-binding domain; LC-DAD — liquid chromatography with (photo) diode array detection; LPS — lipopolysaccharide; MAPK — mitogen-activated protein kinase; NADH — nicotinamide adenine dinucleotide; NAFLD — non-alcoholic fatty liver disease; NF-κb — nuclear factor kappa B; NO — nitric oxide; PI3K — phosphatidylinositol 3 kinase; PKA — protein kinase A; PKC — protein kinase C; PPAR-γ — peroxisome proliferator-activated receptor gamma; ROS — reactive oxygen species; RxR — retinoid X receptor; SEL — sesquiterpene lactones; SUR1 — sulphonylurea receptor 1; T2D — type 2 diabetes; TAG — triacylglycerol; TNF-α — tumor necrosis factor; TO — Taraxacum officinale; TS — taraxasterol; UPLC-MS/MS — ultra-performance liquid chromatography — tandem mass spectrometry; UV/VIS — ultraviolet visible; WHO — World Health Organization.

Read more | >

This could enable for microgrids for sewage disposal and more lucrative businesses in waste reclaiming through making essentially computers with waste.

A synthesis procedure developed by NITech scientists can convert fish scales obtained from fish waste into a useful carbon-based nanomaterial. Their approach uses microwaves to break the scales down thermally via pyrolysis in less than 10 seconds, yielding carbon nano-onions with unprecedented quality compared with those obtained from conventional methods. Credit: Takashi Shirai from NITech, Japan.

Carbon-based nanomaterials are increasingly being used in electronics, energy conversion and storage, catalysis, and biomedicine due to their low toxicity, chemical stability, and extraordinary electrical and optical properties. CNOs, or carbon nano-onions, are by no means an exception. CNOs, which were first described in 1980, are nanostructures made up of concentric shells of fullerenes that resemble cages inside cages. They have several desired qualities, including a large surface area and high electrical and thermal conductivities.

Continue reading “New Method Converts Fish Waste Into Valuable Nanomaterial in Seconds” | >

Right now everyone is talking about mRNA vaccines, such as the Biontech-Pfizer or the Moderna vaccine — but what about DNA-vaccines? Will this be a vaccine type of the future?

Vaccines have saved millions of lives in the past century and for now, they’re the best way out of this crisis. There are exciting new prospects, waiting in the wings. The practice of vaccinating dates back thousands of years through rabbit spines, powdered cowpox and fearless scientists. Today, viral vectors and mRNA technology have been instrumental in fighting COVID-19. With DNA vaccines another technique is already been tested.

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

For more news go to: http://www.dw.com/en/

Continue reading “DNA vaccines explained: The future of vaccination? | COVID-19 Special” | >

A team of scientists from Korea and Egypt have discovered a better way to grow insect-hunting fungi in a lab, according to research published Wednesday in Frontiers in Microbiology.

The fungi can be grown using grains like brown rice but they do not produce much cordycepin, prompting the researchers to suggest insects—which are a richer protein source and the fungi target in nature—as a better alternative. fungi, which infect and zombify insects, are difficult to cultivate but contain chemicals that could help fight cancer and viruses and possibly help treat Covid-19.

Read more | >